David A. Siegel Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Two Sigma Advisers, LP

$41.3 Billion
Q3 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$83.14 - $145.99 $133,024 - $233,584	-1,600 Reduced 1.88%	83,600 $12.2 Million
Q1 2022 May 16, 2022	BUY	$110.08 - $142.92 $4.12 Million - $5.35 Million	37,400 Added 78.24%	85,200 $10.1 Million
Q4 2021 Feb 14, 2022	BUY	$99.73 - $148.48 $887,597 - $1.32 Million	8,900 Added 22.88%	47,800 $6.59 Million
Q3 2021 Nov 15, 2021	BUY	$98.85 - $138.91 $3.85 Million - $5.4 Million	38,900 New	38,900 $5.4 Million
Q2 2021 Aug 16, 2021	SELL	$65.78 - $105.02 $1.61 Million - $2.57 Million	-24,430 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$64.07 - $91.75 $3.38 Million - $4.84 Million	-52,700 Reduced 68.33%	24,430 $1.67 Million
Q4 2020 Feb 16, 2021	SELL	$65.07 - $98.24 $4.11 Million - $6.2 Million	-63,100 Reduced 45.0%	77,130 $6.61 Million
Q3 2020 Nov 16, 2020	BUY	$59.04 - $77.95 $1.39 Million - $1.84 Million	23,600 Added 20.23%	140,230 $9.12 Million
Q2 2020 Aug 14, 2020	SELL	$29.01 - $74.23 $1.49 Million - $3.82 Million	-51,500 Reduced 30.63%	116,630 $8.53 Million
Q1 2020 May 15, 2020	SELL	$27.51 - $57.29 $3.74 Million - $7.8 Million	-136,100 Reduced 44.74%	168,130 $5.72 Million
Q4 2019 Feb 14, 2020	BUY	$40.86 - $57.65 $1.77 Million - $2.49 Million	43,200 Added 16.55%	304,230 $16.6 Million
Q3 2019 Nov 14, 2019	BUY	$37.38 - $49.47 $2.62 Million - $3.47 Million	70,100 Added 36.72%	261,030 $10.9 Million
Q2 2019 Aug 14, 2019	BUY	$39.79 - $67.01 $3.55 Million - $5.98 Million	89,300 Added 87.87%	190,930 $8.36 Million
Q1 2019 May 15, 2019	BUY	$34.52 - $53.29 $2.93 Million - $4.52 Million	84,800 Added 503.86%	101,630 $5.23 Million
Q4 2018 Feb 14, 2019	BUY	$29.75 - $42.9 $500,692 - $722,007	16,830 New	16,830 $622,000

Others Institutions Holding BHVN

# of Institutions

Shares Held

792K

Call Options Held

Put Options Held

View Full List

About Biohaven Pharmaceutical Holding Co Ltd.

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $3.18B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

More about BHVN

Track David A. Siegel's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.

Account